These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 26458389)
1. Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report. Ramchand SK; Chiang CY; Zebaze RM; Seeman E Osteoporos Int; 2016 Feb; 27(2):821-5. PubMed ID: 26458389 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review. Selga J; Nuñez JH; Minguell J; Lalanza M; Garrido M Osteoporos Int; 2016 Feb; 27(2):827-32. PubMed ID: 26501556 [TBL] [Abstract][Full Text] [Related]
3. Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society. van de Laarschot DM; McKenna MJ; Abrahamsen B; Langdahl B; Cohen-Solal M; Guañabens N; Eastell R; Ralston SH; Zillikens MC J Clin Endocrinol Metab; 2020 May; 105(5):1682-99. PubMed ID: 31867670 [TBL] [Abstract][Full Text] [Related]
4. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures. Righetti M; Wach J; Desmarchelier R; Coury F Joint Bone Spine; 2018 May; 85(3):365-367. PubMed ID: 29246529 [TBL] [Abstract][Full Text] [Related]
5. Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures. Starr J; Tay YKD; Shane E Curr Osteoporos Rep; 2018 Aug; 16(4):519-529. PubMed ID: 29951870 [TBL] [Abstract][Full Text] [Related]
6. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. Shane E; Burr D; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster DW; Ebeling PR; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Howe TS; van der Meulen MC; Weinstein RS; Whyte MP J Bone Miner Res; 2014 Jan; 29(1):1-23. PubMed ID: 23712442 [TBL] [Abstract][Full Text] [Related]
7. Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy. Chiang CY; Zebaze RM; Ghasem-Zadeh A; Iuliano-Burns S; Hardidge A; Seeman E Bone; 2013 Jan; 52(1):360-5. PubMed ID: 23072919 [TBL] [Abstract][Full Text] [Related]
9. Antiresorptive-associated spontaneous fractures of both tibiae, followed by an atypical femur fracture during the sequential treatment with alendronate, denosumab then teriparatide. Tan J; Sano H; Poole K BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31340943 [TBL] [Abstract][Full Text] [Related]
10. Atypical fracture of the femur in a patient using denosumab--a case report. Schilcher J; Aspenberg P Acta Orthop; 2014 Feb; 85(1):6-7. PubMed ID: 24460109 [No Abstract] [Full Text] [Related]
11. Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur. Greenspan SL; Vujevich K; Britton C; Herradura A; Gruen G; Tarkin I; Siska P; Hamlin B; Perera S Osteoporos Int; 2018 Feb; 29(2):501-506. PubMed ID: 29085957 [TBL] [Abstract][Full Text] [Related]
12. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide. Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287 [TBL] [Abstract][Full Text] [Related]
13. High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates. Sato H; Kondo N; Nakatsue T; Wada Y; Fujisawa J; Kazama JJ; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I Osteoporos Int; 2017 Aug; 28(8):2367-2376. PubMed ID: 28409215 [TBL] [Abstract][Full Text] [Related]
14. Conservative treatment of recurrent symptoms of an incomplete, atypical femoral fracture associated with glucocorticoid, bisphosphonate, and denosumab therapy in a patient with chronic obstructive pulmonary disease. Lai KH; Chiang CY; Yang RS; Yang KC; Wu CC Acta Clin Belg; 2019 Oct; 74(5):370-374. PubMed ID: 30336748 [No Abstract] [Full Text] [Related]
15. Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up). Leder BZ; Tsai JN; Jiang LA; Lee H Bone; 2017 May; 98():54-58. PubMed ID: 28286299 [TBL] [Abstract][Full Text] [Related]
16. Management of atypical femoral fracture in a patient with osteogenesis imperfecta. Tan JY; Seow CJ BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29269360 [TBL] [Abstract][Full Text] [Related]
17. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment. Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448 [TBL] [Abstract][Full Text] [Related]
18. Bilateral Atypical Femur Fractures After Denosumab in a Bisphosphonate Naive Patient: A Case Report. Goh JKM; Koh JSB; Ng ACM; Png MA; Howe TS Calcif Tissue Int; 2022 Jul; 111(1):96-101. PubMed ID: 35132455 [TBL] [Abstract][Full Text] [Related]
19. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture. Cross MB; Nam D; van der Meulen MC; Bostrom MP J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959 [TBL] [Abstract][Full Text] [Related]
20. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report. Huang HT; Kang L; Huang PJ; Fu YC; Lin SY; Hsieh CH; Chen JC; Cheng YM; Chen CH Menopause; 2012 Dec; 19(12):1360-3. PubMed ID: 22968250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]